PDCD1 and neoplasm: Therefore, the interaction between PD-L1/2 and PD-1 potently inhibits the effector phase of the cytotoxic immune response [17], which directly protects healthy tissues [18,19], but, when amplified in the tumor, also malignant cells [20].